Tag: clinical trials
MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner...
TORONTO - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is...
FDA Issues Guidance for Clinical Research & Product Development
SILVER SPRING, M.D. – The Federal Drug Administration's (FDA) Center for Drug Evaluation and Research issued its final nonbinding recommendations for clinical cannabis research...
Cannabis and Coronavirus: Reopening Amid Unrest, Virus Spikes
Even as civil unrest continued in cities across the United States, since the May 25 death of George Floyd and several police-involved killings of...
House Committee Passes Legislation to Expand Veterans’ Cannabis Access
WASHINGTON, D.C. – The House Veterans’ Affairs Committee (HVAC) today passed two bills regarding veterans’ cannabis access.
The Veterans Equal Access Act (HR 1647), sponsored...
‘Father of Cannabis Research’ Reveals Latest Discoveries
PASADENA, Calif. – Dr. Raphael Mechoulam, Israeli organic chemist and professor who is world-renowned for his groundbreaking work in the discovery of cannabinoids THC...
Review: “Weed the People” Shows Struggles, Successes of Cannabis Meds for Cancer
Now available on Netflix, 2018 documentary “Weed the People,” follows the stories of several young cancer patients—Sophie, Cecilia, AJ, and Chico, who ranged in...
Epidiolex Becomes First FDA Approved Cannabis-based Drug
LONDON – UK-based pharmaceutical company GW Pharmaceuticals on Monday announced that cannabis-based drug Epidiolex has received approval from the U.S. Food and Drug Administration....
Center for Medicinal Cannabis Research Receives $4.7M Grant to Study CBD and Autism
LA JOLLA, Calif. – At the University of California, San Diego this week, the Center for Medicinal Cannabis Research (CMCR) announced it has received...
GB Sciences Pursues FDA-Registered, First-in-Human Trial of Cannabis-based Therapy for Parkinson’s Disease
LAS VEGAS, April 10, 2018/PR Newswire/--. GB Sciences, Inc. (OTCQB: GBLX) is planning to file an Exploratory IND and perform a Phase 0 Clinical...
Clinical Study Shows Medical Cannabis Relieves Fibromyalgia
In a study published in February in peer review Journal of Clinical Rheumatology, researchers found that medical cannabis had “significant favorable effect on patients...
